journal
Journals Current Neurology and Neurosci...

Current Neurology and Neuroscience Reports

https://read.qxmd.com/read/37943477/recent-developments-in-blood-biomarkers-in-neuro-oncology
#21
REVIEW
Jessica B Foster, Mateusz P Koptyra, Stephen J Bagley
PURPOSE OF REVIEW: Given the invasive and high-risk nature of brain surgery, the need for non-invasive biomarkers obtained from the peripheral blood is greatest in tumors of the central nervous system (CNS). In this comprehensive review, we highlight recent advances in blood biomarker development for adult and pediatric brain tumors. RECENT FINDINGS: We summarize recent blood biomarker development for CNS tumors across multiple key analytes, including peripheral blood mononuclear cells, cell-free DNA, cell-free RNA, proteomics, circulating tumor cells, and tumor-educated platelets...
December 2023: Current Neurology and Neuroscience Reports
https://read.qxmd.com/read/37921944/advances-in-treatment-of-diffuse-midline-gliomas
#22
REVIEW
Chantel Cacciotti, Karen D Wright
PURPOSE OF REVIEW: Diffuse midline gliomas (DMGs) generally carry a poor prognosis, occur during childhood, and involve midline structures of the central nervous system, including the thalamus, pons, and spinal cord. RECENT FINDINGS: To date, irradiation has been shown to be the only beneficial treatment for DMG. Various genetic modifications have been shown to play a role in the pathogenesis of this disease. Current treatment strategies span targeting epigenetic dysregulation, cell cycle, specific genetic alterations, and the immune microenvironment...
December 2023: Current Neurology and Neuroscience Reports
https://read.qxmd.com/read/37957525/sleep-duration-and-executive-function-in-adults
#23
REVIEW
Aayushi Sen, Xin You Tai
PURPOSE OF REVIEW: To review the literature examining the relationship between sleep and cognition, specifically examining the sub-domain of executive function. We explore the impact of sleep deprivation and the important question of how much sleep is required for optimal cognitive performance. We consider how other sleep metrics, such as sleep quality, may be a more meaningful measure of sleep. We then discuss the putative mechanisms between sleep and cognition followed by their contribution to developing dementia...
November 14, 2023: Current Neurology and Neuroscience Reports
https://read.qxmd.com/read/37947962/autonomic-manifestations-of-long-covid-syndrome
#24
REVIEW
Rashmin Hira, Kavithra Karalasingham, Jacquie R Baker, Satish R Raj
PURPOSE OF REVIEW: Long-COVID is a novel condition emerging from the COVID-19 pandemic. Long-COVID is characterized by symptoms commonly seen in autonomic disorders including fatigue, brain fog, light-headedness, and palpitations. This article will critically evaluate recent findings and studies on Long-COVID and its physiological autonomic manifestations. RECENT FINDINGS: Studies have reported on the prevalence of different symptoms and autonomic disorders in Long-COVID cohorts...
November 10, 2023: Current Neurology and Neuroscience Reports
https://read.qxmd.com/read/37943476/recent-advances-in-pediatric-medulloblastoma
#25
REVIEW
Kasey Jackson, Roger J Packer
PURPOSE OF REVIEW: Review recent advances in the understanding of pediatric medulloblastoma including etiology, biology, radiology, and management of pediatric medulloblastoma. RECENT FINDINGS: The classic four subgroups have been reclassified and further subdivided based on new molecular findings. Research is revealing the cell origins of the different subtypes of medulloblastoma. There has been continued personalization of management based on molecular parameters...
November 9, 2023: Current Neurology and Neuroscience Reports
https://read.qxmd.com/read/37938472/neurotoxicity-of-cancer-immunotherapies-including-car-t-cell-therapy
#26
REVIEW
Kun-Wei Song, Brian J Scott, Eudocia Q Lee
PURPOSE OF REVIEW: To outline the spectrum of neurotoxicity seen with approved immunotherapies and in pivotal clinical trials including immune checkpoint inhibitors, chimeric antigen receptor T-cell therapy, vaccine therapy, and oncolytic viruses. RECENT FINDINGS: There has been an exponential growth in new immunotherapies, which has transformed the landscape of oncology treatment. With more widespread use of cancer immunotherapies, there have also been advances in characterization of its associated neurotoxicity, research into potential underlying mechanisms, and development of management guidelines...
November 8, 2023: Current Neurology and Neuroscience Reports
https://read.qxmd.com/read/37921943/updates-in-parkinson-s-disease-integrative-therapies-an-evidence-based-review
#27
REVIEW
Sushma Kola, Indu Subramanian
PURPOSE OF REVIEW: This review summarizes recent evidence-based integrative therapies for Parkinson's disease (PD) that may improve motor and non-motor symptoms, enhance quality of life, and alter disease progression. RECENT FINDINGS: Imaging studies have demonstrated that aerobic exercise changes brain structure and function, while strength training improves posture and balance. Loneliness is associated with worsening PD severity, but social prescribing and cognitive behavioral therapy may effectively foster connections...
November 2023: Current Neurology and Neuroscience Reports
https://read.qxmd.com/read/37847487/dysautonomia-hypermobility-spectrum-disorders-and-mast-cell-activation-syndrome-as-migraine-comorbidities
#28
REVIEW
Svetlana Blitshteyn
PURPOSE OF REVIEW: Dysautonomia refers to the dysfunction of the autonomic nervous system and encompasses a wide variety of autonomic symptoms and disorders. The most common autonomic disorders are postural orthostatic tachycardia syndrome (POTS), neurocardiogenic syncope (NCS), and orthostatic hypotension (OH), which may be encountered in clinical practice as part of a triad of dysautonomia, hypermobility spectrum disorders (HSD), and mast cell activation syndrome (MCAS). Migraine is one of the most common comorbidities of POTS, HSD, and MCAS; conversely, these conditions are also prevalent in patients with migraine, especially in those with multiple systemic symptoms, such as chronic dizziness, lightheadedness, orthostatic intolerance, joint pain, and allergic symptoms...
November 2023: Current Neurology and Neuroscience Reports
https://read.qxmd.com/read/37792206/pediatric-multiple-sclerosis-changing-the-trajectory-of-progression
#29
REVIEW
Daniela Castillo Villagrán, E Ann Yeh
PURPOSE OF REVIEW: Multiple sclerosis is a chronic inflammatory disease of the central nervous system. When seen in children and adolescents, crucial stages of brain development and maturation may be affected. Prompt recognition of multiple sclerosis in this population is essential, as early intervention with disease-modifying therapies may change developmental trajectories associated with the disease. In this paper, we will review diagnostic criteria for pediatric multiple sclerosis, outcomes, differential diagnosis, and current therapeutic approaches...
November 2023: Current Neurology and Neuroscience Reports
https://read.qxmd.com/read/37889427/disparities-in-neuro-oncology
#30
REVIEW
Nara Miriam Michaelson, Amanda Watsula, Anu Bakare-Okpala, Maliheh Mohamadpour, Ugonma N Chukwueke, Joshua A Budhu
PURPOSEOF REVIEW: Health disparities are preventable differences in the diagnosis, treatment, and outcomes of many diseases, including central nervous system (CNS) tumors. This review will summarize and compile the existing literature on health disparities in neuro-oncology and provide directions for future research and interventions. RECENT FINDINGS: Patients from historically marginalized groups are more likely to receive inadequate treatment, develop complications, and experience a shorter life expectancy...
October 27, 2023: Current Neurology and Neuroscience Reports
https://read.qxmd.com/read/37870664/immune-checkpoint-inhibitors-in-patients-with-pre-existing-neurologic-autoimmune-disorders
#31
REVIEW
Raissa Aoun, Daniel Gratch, David Kaminetzky, Ilya Kister
PURPOSE OF REVIEW: The use of immune checkpoint inhibitors (ICIs) for oncologic indications is associated with immune-related adverse events (irAEs). Patients with pre-existing autoimmune diseases are at increased risk of irAEs and have largely been excluded from clinical trials of ICIs. Therefore, there is limited data on the safety of safety of ICIs in patients with pre-existing neurologic autoimmune diseases (nAIDs) such as myasthenia gravis and multiple sclerosis. This review aims to synthesize the literature on the post-marketing experience with ICI in patients with pre-existing nAID and to discuss possible strategies for mitigating the risk of post-ICI nAID relapses...
October 23, 2023: Current Neurology and Neuroscience Reports
https://read.qxmd.com/read/37864642/neurological-complications-associated-with-hereditary-bleeding-disorders
#32
REVIEW
Muhammad Qasim Bhatti, Ezekiel Gonzalez-Fernandez, Kunal Bhatia, Afshin A Divani, Mario Di Napoli, Archana Hinduja, Yvonne H Datta
PURPOSE OF REVIEW: Hereditary bleeding disorders may have a wide variety of clinical presentations ranging from mild mucosal and joint bleeding to severe central nervous system (CNS) bleeding, of which intracranial hemorrhage (ICH) is the most dreaded complication. In this review, we will discuss the pathophysiology of specific hereditary bleeding disorders, namely, hemophilia A, hemophilia B, and von Willebrand disease (vWD); their clinical manifestations with a particular emphasis on neurological complications; a brief overview of management strategies pertaining to neurological complications; and a review of literature guiding treatment strategies...
October 21, 2023: Current Neurology and Neuroscience Reports
https://read.qxmd.com/read/37856049/sporadic-late-onset-nemaline-myopathy-current-landscape
#33
REVIEW
Stefan Nicolau, Margherita Milone
PURPOSE OF REVIEW: Sporadic late-onset nemaline myopathy (SLONM) is a rare adult-onset, acquired, muscle disease that can be associated with monoclonal gammopathy or HIV infection. The pathological hallmark of SLONM is the accumulation of nemaline rods in muscle fibers. We review here current knowledge about its presentation, pathophysiology, and management. RECENT FINDINGS: SLONM usually manifests with subacutely progressive proximal and axial weakness, but it can also present with chronic progressive weakness mimicking muscular dystrophy...
October 19, 2023: Current Neurology and Neuroscience Reports
https://read.qxmd.com/read/37856048/the-association-between-cognitive-domains-and-postural-balance-among-healthy-older-adults-a-systematic-review-of-literature-and-meta-analysis
#34
REVIEW
Nahid Divandari, Marie-Louise Bird, Mahdi Vakili, Shapour Jaberzadeh
PURPOSE OF REVIEW: This review aims to explore which cognitive domain is more closely associated with which type of balance (static or dynamic). RESENT FINDING: Based on recent reviews, inhibitory control, a part of cognition, plays a crucial role in balance performance. Previous reviews report significant links between cognition, mobility, and physical function in older adults. However, evidence regarding the relationship between cognition and balance scores remains inconclusive...
October 19, 2023: Current Neurology and Neuroscience Reports
https://read.qxmd.com/read/37837566/post-stroke-everything
#35
REVIEW
Alain Lekoubou, Clever Nguyen, Michelle Kwon, Arsene Daniel Nyalundja, Ankita Agrawal
PURPOSE OF REVIEW: This review aims at providing updates on selected post-stroke complications. We examined recent advances in diagnosing and treating the following post-stroke complications: cognitive impairment, epilepsy, depression, fatigue, tremors, dysphagia, and pain. RECENT FINDINGS: Advances in understanding the mechanisms of post-stroke complications, in general, are needed despite advances made in understanding, treating, and preventing these complications...
October 14, 2023: Current Neurology and Neuroscience Reports
https://read.qxmd.com/read/37831394/rem-behavior-disorder-implications-for-pd-therapeutics
#36
REVIEW
Jeanne S Feuerstein, Amy Amara
PURPOSE: Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia that occurs during REM sleep, characterized by REM sleep without atonia (RSWA) and dream enactment behavior (DEB). RBD is associated with several diseases and medications but most notably is a prodromal feature of synucleinopathies, including Parkinson's disease (PD). This article reviews RBD, its treatments, and implications for PD therapeutics. RECENT FINDINGS: Recent research recognizes RBD as a prodromal marker of PD, resulting in expansion of basic science and clinical investigations of RBD...
October 13, 2023: Current Neurology and Neuroscience Reports
https://read.qxmd.com/read/37792207/exercise-made-accessible-the-merits-of-community-based-programs-for-persons-with-parkinson-s-disease
#37
REVIEW
Anneli Langbroek-Amersfoort, Sabine Schootemeijer, Lars Bouten, Bastiaan R Bloem, Nienke M De Vries
PURPOSE OF REVIEW: Many studies have identified positive effects of physiotherapy and exercise for persons with Parkinson's disease (PD). Most work has thus far focused on the therapeutic modality of exercise as used within physiotherapy programs. Stimulated by these positive findings, there is now a strong move to take exercise out of the clinical setting and to deliver the interventions in the community. Although the goals and effects of many such community-based exercise programs overlap with those of physiotherapy, it has also become more clear that both exercise modalities also differ in various ways...
October 4, 2023: Current Neurology and Neuroscience Reports
https://read.qxmd.com/read/37812369/molecular-profiling-and-targeted-therapies-in-gliomas
#38
REVIEW
Yuli Felistia, Patrick Y Wen
PURPOSE OF REVIEW: Molecular profiling enables the evaluation of genetic alterations for the diagnosis and classification of gliomas and the selection of appropriate therapies. This review summarizes the current role of molecular profiling and targeted therapies for gliomas. RECENT FINDINGS: Molecular profiling is an integral part of the 2021 WHO classification of gliomas. Progress in the development of targeted therapies remains limited due to many factors including the presence of the blood-brain barrier and issues of tumor heterogeneity...
October 2023: Current Neurology and Neuroscience Reports
https://read.qxmd.com/read/37676440/brain-sagging-dementia
#39
REVIEW
Aslan Lashkarivand, Per Kristian Eide
PURPOSE OF REVIEW: Brain sagging dementia (BSD) is a rare but devastating form of early-onset dementia characterized by intracranial hypotension and behavioral changes resembling behavioral variant frontotemporal dementia. This review aims to provide a comprehensive overview of BSD, highlighting its pathomechanism, diagnostic tools, and available treatment options. RECENT FINDINGS: BSD exhibits a complex clinical manifestation with insidious onset and gradual progression of behavioral disinhibition, apathy, inertia, and speech alterations...
October 2023: Current Neurology and Neuroscience Reports
https://read.qxmd.com/read/37670202/sleep-disturbances-in-autoimmune-neurological-diseases
#40
REVIEW
Laura Pérez-Carbonell, Alex Iranzo
PURPOSE OF REVIEW: To summarize the current evidence on the associations between autoimmune neurological diseases (e.g., multiple sclerosis, myasthenia gravis) and sleep disturbances (e.g., insomnia, parasomnias), as well as to review the main characteristics of sleep disorders with an immune-related pathophysiology (e.g., narcolepsy, anti-IgLON5 disease). RECENT FINDINGS: An immune-mediated damage of the areas in the central nervous system that control sleep and wake functions (e...
October 2023: Current Neurology and Neuroscience Reports
journal
journal
34931
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.